Genovefa Papanicolaou, MD
Enriched profileClinical Director of Infectious Diseases and Attending Physician, Infectious Diseases Service · Memorial Sloan Kettering Cancer Center
Genovefa Papanicolaou is Clinical Director of Infectious Diseases and Attending Physician, Infectious Diseases Service at Memorial Sloan Kettering Cancer Center. OpenAlex indexes 293 publications with 11,914 citations (h-index 51); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.
Data verified 16 Oct 2026
Overview
Updated 16 Oct 2026
Genovefa Papanicolaou, MD, is Clinical Director of Infectious Diseases and Attending Physician, Infectious Diseases Service at Memorial Sloan Kettering Cancer Center. The public record shows 293 publications with 11,914 citations (h-index 51), centered on Cytomegalovirus and herpesvirus research, Hematopoietic Stem Cell Transplantation, Viral-associated cancers and disorders. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 11 companies, 1 NIH-funded awards (1999–2003).
- Top research focus: Cytomegalovirus and herpesvirus research
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 9 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 136.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19
Sponsor: Memorial Sloan Kettering Cancer Center
- A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection
Sponsor: Memorial Sloan Kettering Cancer Center
Industry payments
Updated 16 Oct 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202521 payments$42,491openpaymentsdata.cms.gov ↗
- Biotest AGProgram year20252 payments
- Janssen Research & Development, LLCProgram year20258 payments
NIH funding
Updated 16 Oct 2026
1 NIH research award on record, funded 1999–2003 per NIH RePORTER. The latest:
- SITE SPECIFIC INTEGRATION BY ADENO ASSOCIATED VIRUS
Sloan-Kettering Institute for Cancer Res
FY2003$117,423K08AI001589 - SITE SPECIFIC INTEGRATION BY ADENO ASSOCIATED VIRUS
Sloan-Kettering Institute for Cancer Res
FY2002$117,423K08AI001589 - SITE SPECIFIC INTEGRATION BY ADENO ASSOCIATED VIRUS
Sloan-Kettering Institute for Cancer Res
FY2001$117,423K08AI001589
Congress activity
Updated 16 Oct 2026
7 congress contributions (2004–2025) across ASCO, ASH per OpenAlex. The most recent:
- Respiratory syncytial virus (RSV) infection after CAR T-cell therapy
ASH Annual Meeting
ASH2025Co-author - Timing and Immune Status after Cellular Therapies Predict Response to COVID-19 Vaccines
ASH Annual Meeting
ASH2021Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients
The Journal of Infectious Diseases
2023 - Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study
Clinical Infectious Diseases
2023 - Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
Journal of Clinical Investigation
2023
Most-cited works
by citation count (OpenAlex)- 01
- 02Determinants of COVID-19 disease severity in patients with cancerArticle637 citations2020
- 03
- 04Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for CancerArticle420 citations2020
- 05
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/genovefa-papanicolaou-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
synapse.mskcc.org/synapse/people/4645
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →synapse.mskcc.org ↗
Mentions by others
where others cite or feature them- Other
cgtlive.com/view/papanicolaou-managing-infectious-diseases-patients-receiving-stem-cell-transplant-cell-therapy
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cgtlive.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
National University of Athens School of Medicine (Greece)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Board certified
Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Board certified
Infectious Diseases
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Editorial & leadership roles
journal and society appointments- Fellow
Infectious Diseases Society of America (FIDSA)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cgtlive.com ↗ - Chair
Infectious Disease Special Interest Group (ID-SIG), American Society for Transplantation and Cellular Therapy
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cgtlive.com ↗ - Author
ASTCT Series #11: Updated Cytomegalovirus Guidelines in Hematopoietic Cell Transplant and Cellular Therapy Recipients
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cgtlive.com ↗
Secondary affiliations
appointments beyond the home institution- Professor
Weill Cornell Medical College of Cornell University
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cgtlive.com ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →gotoper.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center
Mark Kris, MD
Memorial Sloan Kettering Cancer Center
Yousef Khader
Jordan University of Science and Technology
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Derrick W. Crook
Nuffield Orthopaedic Centre